EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 9th Interim Report
|
EQS-News: Alzchem Group AG
/ Key word(s): Share Buyback/Share Buyback
Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 Trostberg, February 17th, 2025 9th Interim Report In the period from February 10th up to and including February 14th, 2025, a total of 8,730 shares of Alzchem Group AG were acquired as part of the share buyback programme announced on November 29th, 2024. The total number of shares acquired to date as part of this buyback amounts to 70,568. The acquisition was carried out by a financial institution via the stock exchange (XETRA) on behalf of Alzchem Group AG. The total number of repurchased shares, the weighted average price and the aggregated volume (excl. acquisition costs) per day were as follows:
This information as well as the detailed information on the individual daily transactions related to the buy-back programme are also published on the Company's website at https://www.alzchem.com/en/investor-relations/stock/#c18518 in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052. Alzchem Group AG - Managing Board -
17.02.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Alzchem Group AG |
| Dr.-Albert-Frank-Str. 32 | |
| 83308 Trostberg | |
| Germany | |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | ir@alzchem.com |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 2087235 |
| End of News | EQS News Service |
|
|
2087235 17.02.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 376,07 | 379,26 | 422,29 | 542,22 | 540,65 | 554,23 | 580,00 | |
| EBITDA1,2 | 50,08 | 53,81 | 62,05 | 61,44 | 81,37 | 105,27 | 113,00 | |
| EBITDA-Margin3 | 13,32 | 14,19 | 14,69 | 11,33 | 15,05 | 18,99 | 19,48 | |
| EBIT1,4 | 30,59 | 30,71 | 37,57 | 35,90 | 55,47 | 78,95 | 86,00 | |
| EBIT-Margin5 | 8,13 | 8,10 | 8,90 | 6,62 | 10,26 | 14,25 | 14,83 | |
| Net Profit (Loss)1 | 18,15 | 19,87 | 27,76 | 30,22 | 34,79 | 54,25 | 59,00 | |
| Net-Margin6 | 4,83 | 5,24 | 6,57 | 5,57 | 6,44 | 9,79 | 10,17 | |
| Cashflow1,7 | 43,63 | 48,71 | 43,02 | -4,24 | 72,67 | 105,15 | 86,00 | |
| Earnings per share8 | 1,77 | 1,94 | 2,72 | 2,96 | 3,40 | 5,31 | 5,80 | |
| Dividend per share8 | 0,75 | 0,77 | 1,00 | 1,05 | 1,20 | 1,80 | 1,80 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: RSM Ebner Stolz
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Alzchem Group | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A2YNT3 | DE000A2YNT30 | AG | 1.050,20 Mio € | Kaufen | 8FWJ2HC2+23 | |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 17,49 | 14,08 | 1,24 | 34,87 | 5,61 | 9,99 | 1,89 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 1,05 | 1,20 | 1,80 | 1,74% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 08.05.2025 | 30.04.2025 | 30.07.2025 | 30.10.2025 | 28.02.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +30,17% | +69,65% | +81,05% | +138,34% | +3.546,64% |
